Soul Biotechnology Corp [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21
	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q
Cash Flows From Operating Activities
Net loss	-2.1	-0.1	-0.2	0.0	0.0		0.0	0.0
Less : Loss form discontinued operation	0.0
Loss from continuing operations	-2.1	-0.1	-0.2	0.0	0.0		0.0	0.0
Amortization of intangible assets	0.4	0.0	0.0	0.0
Impairment of goodwill and intangible assets	0.6

Adjustments to reconcile net income to net cash from operating activities:
Changes in operating assets and liabilities:
Accounts receivable	0.0	0.0	0.0	0.0
Inventory	0.0	0.0	0.0	0.0
Prepaid and other assets	0.0
Accrued payable and accrued liabilities	0.0	0.0	0.0	0.0	0.0		0.0	0.0
Net cash used in operating activities -continuing operations	-0.1

Net cash used in operating activities -discontinued operations	0.0
Net cash used in operating activities	0.0	0.0	-0.2	0.0	0.0		0.0	0.0

Cash Flows from Investing Activities
Acquisition of a business net of cash acquired				0.0
Net cash (used in) provided by investing activities				0.0

Cash Flows From Financing Activities
Proceeds from the sale of common stock	0.0
Common stock payable			0.2	0.0
Proceeds from related party loans, net of repayments	0.0	0.0	0.0	0.0	0.0		0.0	0.0
Net cash provided by financing activities	0.0	0.0	0.2	0.0	0.0		0.0	0.0
Effect of exchange rates on cash and cash equivalents	0.0	0.0
Net (decrease) increase in cash and cash equivalents	0.0	0.0	0.0	0.0	0.0		0.0	0.0

Supplemental disclosure of cash flow information
Cash paid for income tax expense
Cash paid for interest expense